A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia

Gabriella Cirmena; Stefania Aliano; Giuseppina Fugazza; Roberto Bruzzone; Anna Garuti; Renata Bocciardi; Andrea Bacigalupo; Roberto Ravazzolo; Alberto Ballestrero; Mario Sessarego

doi:10.1016/j.cancergencyto.2008.02.005

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia

Gabriella Cirmena, Stefania Aliano, Giuseppina Fugazza, Roberto Bruzzone, Anna Garuti, Renata Bocciardi, Andrea Bacigalupo, Roberto Ravazzolo, Alberto Ballestrero, Mario Sessarego

Research output: Contribution to journal › Article

Abstract

We report the occurrence of a BCR-JAK2 fusion gene in a case of acute myeloid leukemia (AML) resulting from a t(9;22)(p24;q11) translocation as the sole cytogenetic abnormality. The BCR-JAK2 fusion gene has the same breakpoint in BCR as is found in the BCR/ABL p210. The chimeric gene is the result of a reciprocal translocation between chromosomes 9 and 22, which implies a double break on chromosome 9; this has allowed generating an in-frame fusion transcript. Previously, BCR-JAK2 rearrangement was observed in a single case with atypical chronic myelogenous leukemia (CML), but in that case the breakpoint in the BCR was different.

Original language	English
Pages (from-to)	105-108
Number of pages	4
Journal	Cancer Genetics and Cytogenetics
Volume	183
Issue number	2
DOIs	https://doi.org/10.1016/j.cancergencyto.2008.02.005
Publication status	Published - Jun 2008

Fingerprint

ASJC Scopus subject areas

Cancer Research
Genetics
Molecular Biology

Cite this

Cirmena, G., Aliano, S., Fugazza, G., Bruzzone, R., Garuti, A., Bocciardi, R., Bacigalupo, A., Ravazzolo, R., Ballestrero, A., & Sessarego, M. (2008). A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia. Cancer Genetics and Cytogenetics, 183(2), 105-108. https://doi.org/10.1016/j.cancergencyto.2008.02.005

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia. / Cirmena, Gabriella; Aliano, Stefania; Fugazza, Giuseppina; Bruzzone, Roberto; Garuti, Anna; Bocciardi, Renata; Bacigalupo, Andrea; Ravazzolo, Roberto; Ballestrero, Alberto; Sessarego, Mario.

In: Cancer Genetics and Cytogenetics, Vol. 183, No. 2, 06.2008, p. 105-108.

Research output: Contribution to journal › Article

Cirmena, Gabriella ; Aliano, Stefania ; Fugazza, Giuseppina ; Bruzzone, Roberto ; Garuti, Anna ; Bocciardi, Renata ; Bacigalupo, Andrea ; Ravazzolo, Roberto ; Ballestrero, Alberto ; Sessarego, Mario. / A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia. In: Cancer Genetics and Cytogenetics. 2008 ; Vol. 183, No. 2. pp. 105-108.

@article{f395e394f3ec444fbb06bd5d21c99063,

title = "A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia",

abstract = "We report the occurrence of a BCR-JAK2 fusion gene in a case of acute myeloid leukemia (AML) resulting from a t(9;22)(p24;q11) translocation as the sole cytogenetic abnormality. The BCR-JAK2 fusion gene has the same breakpoint in BCR as is found in the BCR/ABL p210. The chimeric gene is the result of a reciprocal translocation between chromosomes 9 and 22, which implies a double break on chromosome 9; this has allowed generating an in-frame fusion transcript. Previously, BCR-JAK2 rearrangement was observed in a single case with atypical chronic myelogenous leukemia (CML), but in that case the breakpoint in the BCR was different.",

author = "Gabriella Cirmena and Stefania Aliano and Giuseppina Fugazza and Roberto Bruzzone and Anna Garuti and Renata Bocciardi and Andrea Bacigalupo and Roberto Ravazzolo and Alberto Ballestrero and Mario Sessarego",

year = "2008",

month = jun

doi = "10.1016/j.cancergencyto.2008.02.005",

language = "English",

volume = "183",

pages = "105--108",

journal = "Cancer Genetics and Cytogenetics",

issn = "0165-4608",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia

AU - Cirmena, Gabriella

AU - Aliano, Stefania

AU - Fugazza, Giuseppina

AU - Bruzzone, Roberto

AU - Garuti, Anna

AU - Bocciardi, Renata

AU - Bacigalupo, Andrea

AU - Ravazzolo, Roberto

AU - Ballestrero, Alberto

AU - Sessarego, Mario

PY - 2008/6

Y1 - 2008/6

N2 - We report the occurrence of a BCR-JAK2 fusion gene in a case of acute myeloid leukemia (AML) resulting from a t(9;22)(p24;q11) translocation as the sole cytogenetic abnormality. The BCR-JAK2 fusion gene has the same breakpoint in BCR as is found in the BCR/ABL p210. The chimeric gene is the result of a reciprocal translocation between chromosomes 9 and 22, which implies a double break on chromosome 9; this has allowed generating an in-frame fusion transcript. Previously, BCR-JAK2 rearrangement was observed in a single case with atypical chronic myelogenous leukemia (CML), but in that case the breakpoint in the BCR was different.

AB - We report the occurrence of a BCR-JAK2 fusion gene in a case of acute myeloid leukemia (AML) resulting from a t(9;22)(p24;q11) translocation as the sole cytogenetic abnormality. The BCR-JAK2 fusion gene has the same breakpoint in BCR as is found in the BCR/ABL p210. The chimeric gene is the result of a reciprocal translocation between chromosomes 9 and 22, which implies a double break on chromosome 9; this has allowed generating an in-frame fusion transcript. Previously, BCR-JAK2 rearrangement was observed in a single case with atypical chronic myelogenous leukemia (CML), but in that case the breakpoint in the BCR was different.

UR - http://www.scopus.com/inward/record.url?scp=43949133894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949133894&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2008.02.005

DO - 10.1016/j.cancergencyto.2008.02.005

M3 - Article

C2 - 18503828

AN - SCOPUS:43949133894

VL - 183

SP - 105

EP - 108

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -

Access to Document

10.1016/j.cancergencyto.2008.02.005